Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vesomni for LUTS Associated With BPH (Neptune)
NCT01018511Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2010
- Primary completion
- Mar 2011
- Countries
- 13
01
Overview
A Phase 3 trial of solifenacin + tamsulosin in benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), sponsored by Astellas Pharma. Started Jan 2010; status: completed.
02
Drugs
solifenacin + tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT01018511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018511.